Transforming growth factor-β1 and vascular endothelial growth factor levels in senile acute myeloid leukemia and correlation with prognosis

Table 4 Vascular endothelial growth factor and transforming growth factor-β1 expression in patients with acute myeloid leukemia with different treatment responses

Item	VEGF	TGFβ1
Healthy control (n = 56)	2.41 ± 0.12	0.45 ± 0.09
Complete response (n = 36)	2.42 ± 0.10a	0.43 ± 0.11a
Partial response (n = 23)	2.58 ± 0.13a	0.37 ± 0.13a
No response (n = 21)	2.67 ± 0.11a	0.34 ± 0.09a
t	35.927	11.439
P value	< 0.001	< 0.001

^aP < 0.05 compared with the healthy control group.

VEGF: Vascular endothelial growth factor; TGF-β1: Transforming growth factor-β1.